Evidence map›Paper›PMID 35431918›Full record

ArticleFrontiers in pharmacology2022

The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice.

Laura Nickel, Annika Sünderhauf, Elias Rawish, Ines Stölting, Stefanie Derer, Christoph Thorns, Urte Matschl, Alaa Othman, Christian Sina, Walter Raasch

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Laura NickelInstitute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.
Annika SünderhaufDivision of Nutritional Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany.
Elias RawishInstitute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.
Ines StöltingInstitute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.
Stefanie DererDivision of Nutritional Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany.
Christoph ThornsInstitute of Pathology, University of Lübeck, Lübeck, Germany.
Urte MatschlDepartment Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Alaa OthmanCBBM (Centre of Brain, Behaviour and Metabolism), University of Lübeck, Lübeck, Germany.
Christian SinaDivision of Nutritional Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany.
Walter RaaschInstitute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.
University of Lübeck · DEGerman Centre for Cardiovascular Research · DELeibniz Institute of Virology (LIV) · DEUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The angiotensin II (type 1) (AT

Indexed as

AT1 receptor antagonistdiet induced obesity (DIO)goblet cellMUC2 gene expressionmucus thicknessnecroptosisobesitytelmisartan

Identifiers

PMID35431918
PMCPMC9009210
OpenAlexW4220724555

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.